Haemonetics vs Merit Medical Systems
Haemonetics (HAE), health care, and Merit Medical Systems (MMSI), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Haemonetics is worth $5.5B on the stock market and Merit Medical Systems $5.1B: Haemonetics is valued at 9% more. Haemonetics trades at 53.5 times earnings and Merit Medical Systems at 31.6; operating margins in their latest fiscal years were 11.7% and 12.2%. Over the past year Haemonetics's share price has moved +63.1% and Merit Medical Systems's +2.59%.
Key facts
- Haemonetics market value
- $5.5B
- Merit Medical Systems market value
- $5.1B
- Haemonetics P/E
- 53.5
- Merit Medical Systems P/E
- 31.6
- Haemonetics revenue
- $1.3BFY to 2026-03-28
- Merit Medical Systems revenue
- $1.5BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Haemonetics | Merit Medical Systems |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2026-03-28 | 2025-12-31 |
| Size | ||
| Market cap | $5.5Bhigher | $5.1Blower |
| Revenue | $1.3Blower | $1.5Bhigher |
| Earnings | $97.3Mlower | $128.5Mhigher |
| Employees | 3,009lower | 7,500higher |
| Total assets | $2.4Blower | $2.7Bhigher |
| Valuation | ||
| P/E | 53.5higher | 31.6lower |
| P/S | 4.1higher | 3.3lower |
| P/B | 6.1higher | 2.9lower |
| Dividend yield | 0.00% | 0.00% |
| Profitability | ||
| Operating margin | 11.7%lower | 12.2%higher |
| Balance sheet | ||
| Net assets | $796.3Mlower | $1.6Bhigher |
| Total liabilities | $1.6Bhigher | $1.1Blower |
| Total debt | $1.2Bhigher | $734Mlower |
| Cash on hand | $245.4Mlower | $446.4Mhigher |
| Price change | ||
| Today | -0.35%higher | -2.15%lower |
| 1 year | +63.1%higher | +2.59%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Haemonetics only (1)
- John Rogers2.4%
Merit Medical Systems only (2)
- Adam Katz2.7%
- Lee Ainslie0.6%
Percentages are each holding's share of that investor's reported portfolio. Who owns HAE · Who owns MMSI
More on Haemonetics
Further comparisons
Haemonetics against its closest peers
Merit Medical Systems against its closest peers
Learn
Questions and answers
Which is bigger, Haemonetics or Merit Medical Systems?
By market value, Haemonetics is the larger: $5.5B against $5.1B for Merit Medical Systems. By revenue in its latest fiscal year, Merit Medical Systems is the larger: $1.5B against $1.3B for Haemonetics.
Which has the higher P/E ratio?
Haemonetics: 53.5, against 31.6 for Merit Medical Systems. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Merit Medical Systems: 12.2%, against 11.7% for Haemonetics. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Haemonetics: $1.2B, against $734M for Merit Medical Systems. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Haemonetics and Merit Medical Systems?
None of the tracked superinvestors holds both in their latest 13F filing. 1 holds Haemonetics and 2 hold Merit Medical Systems.
Cite this page
Funkfolio, “Haemonetics vs Merit Medical Systems”, data as of 18 November 2026. https://funkfolio.com/compare/hae-vs-mmsi
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.